跳至主要内容
临床试验/EUCTR2008-004220-23-IT
EUCTR2008-004220-23-IT进行中(未招募)不适用

EFFECT OF SUPPLEMENTATION WITH CHOLECALCIFEROL ON GLUCOSE AND LIPID METABOLISM, BLOOD PRESSURE, BONE MASS, QUALITY OF LIFE, CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHAEMIC HEART DISEASE - ND

AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点开始时间: 2008年7月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients of both sexes 60-80 year old, admitted in hospital for acute coronary syndrome (unstable angina, acute myocardial infarction). No clinical evidence of heart failure (class 1 according to the classification of the New York Heart Association)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hypercalcemia and / or hypercalciuria, nephrolithiasis, chronic renal failure (creatinine clearance <60 ml / min)
  • Patients suffering from chronic diseases (onco-haematological, endocrinological, nutritional, rheumatic, COPD) which can affect bone metabolism
  • Congestive heart failure NYHA ≥ 2 and / or cardiac arrhythmias
  • Patients already in therapy with supplements of calcium and vitamin D
  • Drugs which can affect calcium phosphoric metabolism: cortisone, l-thyroxine in soppressive dose, phenytoin, phenobarbital, chemotherapy drugs (type methotrexate or other antimetabolites), GnRH agonists, progesterone depot, aromatase inhibitors, lithium, antacids chelating phosphates, tetracycline, phenothiazine, cyclosporine, tacrolimus.

研究者

发起方
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

相似试验

EFFECT OF SUPPLEMENTATION WITH CHOLECALCIFEROL ON... | 临床试验